GFH009

GFH009 · Genfleet Therapeutics (Shanghai) Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GFH009, covering 2024-12-13 to 2025-08-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL [Phase 1, Phase 2]

See pricing